Invest Now
Samco securities limited
Samco Star Rating Ads

Gufic BioSciences Ltd

₹ 327.35 +8.05 (2.51%)

Updated on 27-04-2024 6:56 AM

Stock Rating

Pros 1

 

Cons 6

Price Performance

  • Day's Low
  • ₹319
  • Day's High
  • ₹332.35
₹ 327.35
  • 52-w low
  • ₹193.55
  • 52-w high
  • ₹364.9
327.35
  • Day's open
    ₹324
  • Previous close
    ₹320.75
  • VWAP
    ₹326.1
  • Lower price band
    ₹261.9
  • Upper price band
    ₹392.8

Today's Market Action

The last traded share price of Gufic BioSciences Ltd was 327.35 up by 2.51% on the NSE. Its last traded stock price on BSE was 327.70 up by 2.31%. The total volume of shares on NSE and BSE combined was 135,171 shares. Its total combined turnover was Rs 4.41 crores.

Medium and Long Term Market Action

Gufic BioSciences Ltd hit a 52-week high of 364.9 on 30-01-2024 and a 52-week low of 193.55 on 06-06-2023. The stock price of Gufic BioSciences Ltd is up by 16% over the last one month. It is up by 64.09% over the last one year. Don't forget to check the full stock price history in the table below.

Fundamentals

  • Market Cap (Cr): 3216

  • Book Value (₹):

  • Stock P/E:

  • Revenue (Cr):

  • Total Debt (Cr):

  • Face Value (₹):

  • Roce (%):

  • ROE (%):

  • Earnings (Cr):

  • Promoter’s Holdings (%):

  • EPS (₹):

  • Debt to Equity:

  • Dividend Yield (%):

  • Cash (Cr):

Mutual fund holdings and trends

FUND NAME Quantity Monthly Change (Qty)

Shareholding Pattern

Similar Stocks

Company Price Market Cap (Cr) P/E

About

Data not available.

FAQ's

What is Share Price of Gufic BioSciences Ltd?

What is the Market Cap of Gufic BioSciences Ltd?

What is PE Ratio of Gufic BioSciences Ltd?

What is PB Ratio of Gufic BioSciences Ltd?

What is the CAGR of Gufic BioSciences Ltd?

How to Buy Gufic BioSciences Ltd Share?

(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

Pros

  • Above Average Sustainable RoE
    The company generates a sustainable return on equity greater than the expected cost of capital which implies that the underlying business can create and compound value over a period time due to it's ability to generate above average return on capital.

Cons

  • Momentum Strength
    The stock is currently exhibiting weak momentum, & is showing weak relative strength.
  • Low Return on Capital Employed
    The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
  • Poor Cash Flow Conversion
    The business has very poor cash conversion ratio of only -19.71% of operating earnings getting converted into operating cash flow. This implies that increase in profits has not translated into higher cash flows for the business and incrementally higher investments in working capital which works negatively for shareholders.
  • Highly Cyclical Industry
    The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
  • Capital Intensive Business
    The company operates an extremely capital intensive business with a low Asset turnover ratio of 1.86. A low asset turnover ratio negatively impacts RoE and reduces shareholder returns. Also due to the capital intensive nature of business, growth of the business would need to be funded either via increasing borrowings or diluting shareholders, both of which shall negatively impact shareholder value and returns.
  • Poor Working Capital Cycle
    The company has a very poor working capital cycle of 212 days which requires very high investments in working capital. This reduces free cash flow generation for the business and negatively impacts shareholder value and returns.

Valuation Analysis

Margin of safety
(27/04/2024)
Stock Valuation
Green line
97
100.00%
100.00% People are bullish about Gufic BioSciences Ltd
0.00%
0.00 % People are bearish about Gufic BioSciences Ltd

What is your opinion about this Stock?

Historical Data

Samco Star Rating Ads

Gufic BioSciences Ltd

₹ 327.35 +8.05 (2.51%)

Brokerage & Taxes at Samco

Brokerage & Taxes at Other traditional broker

Potential Brokerage Savings with Samco ₹ 49.62()

Top Gainers (NIFTY 50)

Stock Name Change %

    Top Losers (NIFTY 50)

    Stock Name Change %

      ×

      Filing Complaints on SCORES

      Easy & quick Easy & quick

      1. Register on SCORES portal

      2. Mandatory details for filling complaints on SCORES

      Name | PAN | Address | Mobile | Number | E-mail ID

      3. Benefits

      Effective Communication

      Speedy redressal of the grievances

      Website Icon